Media stories about Aceto (NASDAQ:ACET) have been trending somewhat positive on Sunday, Accern reports. The research firm ranks the sentiment of media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Aceto earned a media sentiment score of 0.13 on Accern’s scale. Accern also gave news coverage about the company an impact score of 45.1799540423345 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Several equities research analysts have weighed in on ACET shares. ValuEngine upgraded Aceto from a “sell” rating to a “hold” rating in a report on Thursday, August 2nd. Canaccord Genuity reiterated a “sell” rating and issued a $2.00 price objective on shares of Aceto in a report on Thursday, May 10th. Finally, Craig Hallum cut Aceto from a “hold” rating to a “sell” rating in a report on Thursday, April 19th. Four equities research analysts have rated the stock with a sell rating and one has given a hold rating to the stock. The stock presently has a consensus rating of “Sell” and a consensus target price of $2.00.

Shares of Aceto traded down $0.12, reaching $3.14, on Friday, according to MarketBeat.com. The stock had a trading volume of 123,898 shares, compared to its average volume of 220,117. The stock has a market cap of $100.37 million, a PE ratio of 2.64 and a beta of 1.62. The company has a quick ratio of 0.80, a current ratio of 1.12 and a debt-to-equity ratio of 0.63. Aceto has a 12-month low of $2.22 and a 12-month high of $16.51.

Aceto Company Profile

Aceto Corporation, together with its subsidiaries, sources, markets, sells, and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products, and specialty chemicals. The company operates in three segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals.

Featured Article: Price to Earnings Ratio (PE) Basics

Insider Buying and Selling by Quarter for Aceto (NASDAQ:ACET)

Receive News & Ratings for Aceto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aceto and related companies with MarketBeat.com's FREE daily email newsletter.